Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin secures SBTi validation for emission reduction targets

Lupin to buy Medisol for around 160 crore

Ruchika Sharma6 May 2023 11:43 AM IST

With this acquisition, Lupin will gain access to Medisol's portfolio of seven injectable products across four therapeutic areas, including pain...

Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillation

EU needs tiered drug pricing to improve patient access: Bayer exec

Ruchika Sharma6 May 2023 9:00 AM IST

Boston: The European Union should put mechanisms in place to allow drugmakers to charge higher prices in wealthy European countries and lower...

Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA

Hasten Biopharma acquires commercial rights for Roche's Rocephin in China

Ruchika Sharma5 May 2023 5:38 PM IST

Shanghai: Hasten Biopharmaceutic Co., Ltd (China) has announced that it has acquired the commercial rights in China for Rocephin from Swiss...

CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibbs Mavacamten Study

Bristol Myers Squibb gets European Commission nod for CAR T Cell therapy Breyanzi for relapsed or refractory large B-cell lymphoma after one prior therapy

Ruchika Sharma5 May 2023 2:30 PM IST

Breyanzi is a CD19-directed CAR T cell therapy with a 4-1BB costimulatory domain, which enhances the expansion and persistence of the CAR T cells.

Trodelvy plus Keytruda effective for aggressive breast cancer type: Gilead Sciences

Gilead Sciences gets EMA panel postive opinion recommending full marketing nod of Hepcludex for HDV

Ruchika Sharma5 May 2023 1:30 PM IST

Foster City: Gilead Sciences, Inc. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

Pfizer discontinues development of danuglipron for chronic weight management

Pfizer beats Q1 profit estimates on demand for newly acquired drugs, COVID products

Ruchika Sharma5 May 2023 12:30 PM IST

The company said it expects significantly lower sales contributions from COVID products in the second quarter from the first quarter.

USFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoea

Zydus Lifesciences bags USFDA nod for ulcer drug Sucralfate

Ruchika Sharma5 May 2023 11:34 AM IST

Ahmedabad: Pharma major, Zydus Lifesciences Limited, has announced that the company has received final approval from the United States Food and Drug...

Novartis division Sandoz to exclusively commercialize six products in US across key therapeutic areas

Ruchika Sharma4 May 2023 5:40 PM IST

Basel: Sandoz has announced that it has signed a distribution and collaboration agreement with Adalvo for exclusive Sandoz rights to commercialize six...

Lupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli Ulcer

Janssen Biotech, Cellular Biomedicine Group collaborate to develop next generation CAR-T therapies

Ruchika Sharma4 May 2023 3:30 PM IST

Under terms of the agreement, CBMG will grant Janssen a worldwide license to develop and commercialize the CAR-T assets, except in Greater China.

Medical shop owner duped of Rs 2.2 crore, FIR registered

Ruchika Sharma4 May 2023 2:37 PM IST

Mumbai: The Mumbai Police have registered an FIR against a father-son duo involved in dairy products business and a real estate agent for allegedly...

Pfizer plan to sell its Haleon stake is not surprise: Consumer health company Finance chief

Ruchika Sharma4 May 2023 1:30 PM IST

Hestler said Pfizer has long been clear about its intention to sell off the stake, suggesting that the reason the potential of the selloff has gained...

DCGI okays AstraZeneca's breast cancer drug Trastuzumab deruxtecan

Ruchika Sharma4 May 2023 12:41 PM IST

The HER2 is a tyrosine kinase receptor growth-promoting protein expressed on the surface of multiple tumours including breast, gastric, lung and...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok